Bottom line
- Total investment $198K – $403K including a $50K franchise fee, 6.0% ongoing royalty.
- Average unit revenue of $617K/year (median $560K). Estimated payback in 0.8 years.
- Rated STRONG with a risk score of 22/100. SBA loan default rate of 0.0% across 18 loans (below the industry average).
- Auditor disclosed a going-concern note — flagged doubt about the franchisor's ability to continue operations. Verify against the latest FDD.
Item 1 · who you're contracting with
The Franchisor
Yale framework · single-unit ROIC
Returns Analysis
Pulls Item 7 (investment) and Item 19 (revenue) from this brand's FDD into the Yale unlevered-ROIC formula. Override any input to stress-test it against your own assumptions.
The model · Yale framework
What would one IV Nutrition unit return on the cash you put in?
Unlevered ROIC · per unit
38%
In Yale's "attractive" band (30–60%)
Levered LBO scenario · Yale Crease Capital framing
What would 25 IV Nutrition units return on equity?
Equity IRR · 5-yr
49.9%
7.57× MOIC
Year-1 DSCR
1.88×
EBITDA ÷ debt service
Equity required
$1.9M
on $9.3M purchase
Total debt
$7.4M
SBA $4.6M + senior + seller note
Overview
About
IV Nutrition franchisees operate medical-style infusion clinics offering intravenous hydration, vitamin, and nutrient therapies to wellness-focused customers. Daily operations include patient intake, IV administration under nursing/medical supervision, inventory management, compliance with healthcare regulations, and marketing to local clientele.
Item 7 · what it costs
The Vitals
Item 19
Financial Performance
Item 20 · unit dynamics
The Growth Chart
Year-over-year franchised unit counts and net change. Source: FDD Item 20.
Item 20 · 27 states with active franchisees
The Territory Map
Derived from franchisee contact records. Shows states with at least one current operator — not where the franchisor is registered to sell new units (that data is re-extracting in a future refresh).
States derived from franchisee phone area codes (Item 20). Approximate — ported numbers may show the original state, not the franchisee's current location.
Government records
SBA Loan Data
Aggregated from SBA 7(a) loan disclosures, public data unique to FranchiseVerdict.
FranchiseVerdict rating + FDD Items 3, 5, 6, 12, 17
Risk & Legal
IV Nutrition presents moderate risk with tight unit economics, unverified financial claims, and a small-scale system in a niche wellness market.
Score breakdown · what drove the 22 / 100 rating
- 01MEDHigh initial investment ($198K-$402K) relative to average net income ($392K) creates tight ROI timeline with limited margin for error
- 02MEDSmall franchise system (31 units) with only 21.1% YoY growth suggests limited brand recognition and scaling challenges
- 03MEDNo Item 19 financial performance representations disclosed — average revenue/net income figures are unverified and may not be representative
- 04MINORService-based model (IV therapy) is location-dependent and sensitive to local competition, staffing costs, and regulatory changes
Severity inferred from the FDD text · not a regulatory classification
FDD Items 5, 6, 12, 17 · continued from Risk & Legal
Contract & Territory Detail
Item 11
Training & Operations
Item 20
Franchisee Contacts
Phone numbers extracted directly from this brand's FDD Item 20. After purchase, you'll also receive a list of validation questions tailored to this brand.
Franchisee contacts
53 numbers
One-time purchase · CSV download · Validation questions included
FDD download
IV Nutrition · FDD (2025) PDF